AFP member of anti-disinformation platform in Germany and Austria

The largest collaborative project between fact-checking teams and scientists in the German-speaking world, the German-Austrian Digital Media Observatory (GADMO) will be launched on November 1.

The largest collaborative project between fact-checking teams and scientists in the German-speaking world, the German-Austrian Digital Media Observatory (GADMO) will be launched on November 1.
Anglais

AFP joins five new European hubs to fight disinformation

The European Commission has selected Agence France-Presse (AFP), a global leader in digital investigation, to be part of five new hubs dedicated to the fight against disinformation in 10 European countries.

The European Commission has selected Agence France-Presse (AFP), a global leader in digital investigation, to be part of five new hubs dedicated to the fight against disinformation in 10 European countries.
Anglais

AFP’s fact-checks cited as benchmark by German study

Germany’s respected Grimme institute has just published a comparative analysis of fact-checking organisations in the country, which highlights the quality of Agence France-Presse’s digital verification production.

Germany’s respected Grimme institute has just published a comparative analysis of fact-checking organisations in the country, which highlights the quality of Agence France-Presse’s digital verification production.
Anglais

AFP to press charges over attack at Paris anti-vax rally

AFP is to press charges after one of its staff was attacked in Paris on Saturday during a rally against the introduction of a vaccine pass.

AFP is to press charges after one of its staff was attacked in Paris on Saturday during a rally against the introduction of a vaccine pass.
07/01/2026 10:15
AngloGold Ashanti Publishes Notice of General Meeting in Relation to Proposed Share Repurchase Programme

Shareholders of AngloGold Ashanti plc ("AngloGold Ashanti", "AGA" or the "Company") (NYSE: AU; JSE: ANG) are advised that the Company has today, Wednesday 1 July 2026, published its notice of meeting (the "Notice") for a general meeting of its shareholders in relation to the proposed share repurchase programme (the "General Meeting"). The General Meeting is scheduled to be held at AGA’s global headquarters at 6363 S. Fiddlers Green Circle, Suite 1000, Greenwood Village, CO 80111, USA at 9:00 a....

07/01/2026 10:34
Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States

Wrapping up the first half of 2026 with another important milestone, Croma-Pharma announces the FDA approval of Obagi saypha® ChIQ™ in the United States. Obagi saypha® ChIQ™ injectable hyaluronic acid gel is approved for cheek augmentation and correction of midface contour deficiencies in adults over the age of 21. Developed and manufactured by Croma-Pharma and commercialized by Obagi Medical, a Waldencast company, in the U.S., ChIQ™ follows the approval of Obagi saypha® MagIQ™ in September 2...

Subscribe to